Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006
- PMID: 20585732
- DOI: 10.1590/s0036-36342010000700011
Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006
Abstract
Objective: To describe the trends in the prevalence of type 2 diabetes (T2D), and other cardiovascular risk factors in three national health surveys (1993, 2000 and 2006).
Materials and methods: The databases of three surveys: ENEC 1993, ENSA 2000 and ENSANUT 2006 were gathered. Calculations of published data were reprocessed to do appropriate adjustments to assure comparability among surveys.
Results: From 1993 to 2006 the prevalence of type 2 diabetes (6.7-14.4%), metabolic syndrome (26.6-36.8%), hypertension (23.8-30.7%), hypercholesterolemia (27-43.6%), and high LDL-cholesterol (31.6-46%) increased rapidly. The prevalence of low HDL cholesterol was very high (60.5-63%) in all surveys and remained remarkably unchanged among surveys.
Conclusions: This increasing trends for the prevalence of T2D and cardiovascular risk factors predicts larger increments in the near future for T2D and cardiovascular morbidity and mortality. Intensification of the preventive and remedy strategies is mandatory in order curve the foreseen dramatic increment in the disease burden.
Similar articles
-
Methodology for the analysis of type 2 diabetes, metabolic syndrome and cardiovascular disease risk indicators in the ENSANUT 2006.Salud Publica Mex. 2010;52 Suppl 1:S4-10. doi: 10.1590/s0036-36342010000700003. Salud Publica Mex. 2010. PMID: 20585728
-
Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006.Salud Publica Mex. 2010;52 Suppl 1:S44-53. doi: 10.1590/s0036-36342010000700008. Salud Publica Mex. 2010. PMID: 20585729
-
Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006.Salud Publica Mex. 2010;52 Suppl 1:S63-71. doi: 10.1590/s0036-36342010000700010. Salud Publica Mex. 2010. PMID: 20585731
-
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.Endocrine. 2006 Feb;29(1):109-17. doi: 10.1385/ENDO:29:1:109. Endocrine. 2006. PMID: 16622298 Review.
-
Cardiovascular risk factors in the Mexican population.Ren Fail. 2006;28(8):677-87. doi: 10.1080/08860220600936096. Ren Fail. 2006. PMID: 17162426 Review.
Cited by
-
Design of a cluster-randomized trial of the effectiveness and cost-effectiveness of metformin on prevention of type 2 diabetes among prediabetic Mexican adults (the PRuDENTE initiative of Mexico City).Contemp Clin Trials. 2020 Aug;95:106067. doi: 10.1016/j.cct.2020.106067. Epub 2020 Jun 21. Contemp Clin Trials. 2020. PMID: 32580032 Free PMC article. Clinical Trial.
-
Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes.J Nutr. 2013 Sep;143(9):1474-80. doi: 10.3945/jn.113.177212. Epub 2013 Jul 31. J Nutr. 2013. PMID: 23902957 Free PMC article.
-
Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico.Environ Health Perspect. 2016 Jan;124(1):104-11. doi: 10.1289/ehp.1408742. Epub 2015 Jun 12. Environ Health Perspect. 2016. PMID: 26068977 Free PMC article.
-
Fatty acids intake in the Mexican population. Results of the National Nutrition Survey 2006.Nutr Metab (Lond). 2011 Jun 8;8(1):33. doi: 10.1186/1743-7075-8-33. Nutr Metab (Lond). 2011. PMID: 21651771 Free PMC article.
-
Metabolic syndrome in Mexican women survivors of breast cancer: a pilot study at a general hospital.Med Arch. 2014;68(1):19-21. doi: 10.5455/medarh.2014.68.19-21. Med Arch. 2014. PMID: 24783905 Free PMC article.